AtriCure Inc (ATRC)
NASDAQ
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-05-20 | Ms. Karen N. PrangeIndependent Director | -3.00k | 85.95k | 売り | 28.65 | 26.37k | -10.21% |
| 2026-05-15 | Dr. Vinayak DoraiswamyChief Scientific Officer | -5.00k | 140.65k | 売り | 28.13 | 91.88k | -5.16% |
| 2026-03-12 | Dr. Vinayak DoraiswamyChief Scientific Officer | -5.00k | 149.15k | 売り | 29.83 | 96.88k | -4.91% |
| 2026-03-10 | Mr. Robert S. WhiteIndependent Chairman of the Board | 10.00k | 149.90k | Derivative Exercise and Retained Stock | 14.99 | 122.17k | 8.91% |
| 2026-03-06 | Mr. Michael H. CarrelCEO, President & Director | -6.00k | 0.00 | Other Disposition | - | 796.06k | -0.75% |
| 2026-03-01 | Mr. Salvatore PriviteraChief Technical Officer | -13.13k | 410.35k | Sale to Issuer | 31.26 | 158.05k | -7.67% |
| 2026-03-01 | Mr. Michael H. CarrelCEO, President & Director | -72.78k | 2.28M | Sale to Issuer | 31.26 | 796.06k | -8.38% |
| 2026-03-01 | Mr. Douglas J. SeithCOO | -22.95k | 717.35k | Sale to Issuer | 31.26 | 229.34k | -9.10% |
| 2026-03-01 | Ms. Angela L. WirickCFO | -22.97k | 717.89k | Sale to Issuer | 31.26 | 204.89k | -10.08% |
| 2026-03-01 | Dr. Vinayak DoraiswamyChief Scientific Officer | -15.59k | 487.19k | Sale to Issuer | 31.26 | 101.88k | -13.27% |
| 2026-03-01 | Mr. Justin J. NozneskyChief Marketing & Strategy Officer | -15.59k | 487.22k | Sale to Issuer | 31.26 | 106.40k | -12.78% |
| 2026-03-01 | Mr. Karl S. DahlquistChief Legal Officer | -15.69k | 490.38k | Sale to Issuer | 31.26 | 96.05k | -14.04% |
| 2025-12-10 | Mr. Michael H. CarrelCEO, President & Director | -4.00k | 0.00 | Other Disposition | - | 698.94k | -0.57% |
| 2025-11-24 | Mr. Sven A. WehrweinIndependent Director | -10.00k | 177.08k | Derivative Exercise and Sale | 19.95 - 38.00 | 34.37k | - |
| 2025-11-26 | Mr. Justin J. NozneskyChief Marketing & Strategy Officer | -5.17k | 192.64k | 売り | 37.29 | 78.80k | -6.15% |
| 2025-11-21 | Ms. Maggie S. YuenIndependent Director | -3.00k | 107.16k | 売り | 35.72 | 11.37k | -20.88% |
| 2025-11-13 | Mr. Michael H. CarrelCEO, President & Director | -6.00k | 0.00 | Other Disposition | - | 702.94k | -0.85% |
| 2025-09-12 | Mr. Justin J. NozneskyChief Marketing & Strategy Officer | -3.00k | 108.90k | 売り | 36.30 | 83.96k | -3.45% |
| 2025-08-22 | Mr. Sven A. WehrweinIndependent Director | -5.00k | 85.25k | Derivative Exercise and Sale | 19.95 - 37.00 | 34.37k | - |
| 2025-08-19 | Mr. Sven A. WehrweinIndependent Director | -5.00k | 80.25k | Derivative Exercise and Sale | 19.95 - 36.00 | 34.37k | - |
| 2025-08-08 | Mr. Michael H. CarrelCEO, President & Director | -10.00k | 0.00 | Other Disposition | - | 708.94k | -1.39% |
| 2025-08-06 | Ms. Regina E. GrovesIndependent Director | -2.45k | 90.28k | 売り | 36.82 | 33.72k | -6.78% |
| 2025-08-05 | Dr. Vinayak DoraiswamyChief Scientific Officer | -2.50k | 91.45k | 売り | 36.58 | 71.87k | -3.36% |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。